A meta-analysis: Comparison of esomeprazole and other proton pump inhibitors in eradicating Helicobacter pylori

Digestion

Volumn 73, Issue 2-3, 2006, Pages 178-186

  Wang, Xia ^a   Fang, Jing Yuan ^a   Lu, Rong ^a   Sun, Dan Feng ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Esomeprazole; Helicobacter pylori; Meta analysis; Peptic ulcer; Randomized controlled trials

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CLARITHROMYCIN; ESOMEPRAZOLE; METRONIDAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR;

ABSENCE OF SIDE EFFECTS; CLINICAL TRIAL; COCHRANE LIBRARY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DRUG EFFICACY; DRUG TOLERABILITY; EMBASE; ERADICATION THERAPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; MEDLINE; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; REVIEW; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; TIME SERIES ANALYSIS;

ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CHI-SQUARE DISTRIBUTION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; OMEPRAZOLE; PROTON PUMPS; RANDOMIZED CONTROLLED TRIALS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 33746642175     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000094526     Document Type: Review

References (28)

1. Consensus Proposal of Management Helicobacter pylori Infection (2003): Tongcheng Anhui. Chinese Medical Association Section of Digestive Disease. Chin J Dig 2004;24:126-127.
2. Hassan-Alin M, Andersson T, Niazi M, Rohss K: A pharmacokinetic study comparing single and repeated oral doses of 20 and 40 mg omeprazole and its two optical isomers, S-omeprazole (esomeprazole) and R-omeprazole, in healthy subjects. Eur J Clin Pharmacol 2005;60:779-784.
3. Song FJ, Altman DG, Glenny AM: Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. BMJ 2003;326:472.
4. Hsu PI, Lai KH, Lin CK, Chen WC, Yu HC, Cheng JS, Tsay FW, Wu CJ, Lo CC, Tseng HH, Yamaoka Y, Chen JL, Lo GH: A prospective randomized trail of esomeprazole vs. pantoprazole-based triple therapy for Helicobacter pylori eradication. Am J Gastroenterol 2005;100:2387-2392.
5. Sheu BS, Kao AW, Cheng HC, Hunag SF, Chen TW, Lu CC, Wu JJ: Esomeprazole 40 mg twice daily in triple therapy and the efficacy of Helicobacter pylori eradication related to CYP2C19 metabolism. Aliment Pharmacol Ther 2005;21:283-288.
6. Chen YH, Wang WM, Wang H, Li HY: Comparison of esomeprazole- and omeprazole-based triple therapy regimens for duodenal ulcer with Helicobacter pylori infection. Di Yi Jun Yi Da Xue Xue Bao 2005;25:1045-1047.
7. Anagnostopoulos GK, Tsiakos S, Margantinis G, Kostopoulos P, Arvanitidis D: Esomeprazole versus omeprazole for the eradication of Helicobacter pylori infection: results of a randomized controlled study. J Clin Gastroenterol 2004;38:503-506.
8. Miehlke S, Schneider-Brachert W, Bastlein E, Ebert S, Kirsch C, Haferland C, Buchner M, Neumeyer M, Vieth M, Stolte M, Lehn N, Bayerdorffer E: Esomeprazole-based one-week triple therapy with clarithromycin and metronidazole is effective in eradicating Helicobacter pylori in the absence of antimicrobial resistance. Aliment Pharmacol Ther 2003;18:799-804.
9. Veldhuyzen Van Zanten S, Machado S, Lee J: One-week triple therapy with esomeprazole, clarithromycin and metronidazole provides effective eradication of Helicobacter pylori infection. Aliment Pharmacol Ther 2003;17:1381-1387.
10. Maev IV, Kurilo AE, V'iuchnova ES, Shchekina MI: Esomeprazole in treating duodenal ulcer in various modes of anti-Helicobacter therapy. Ter Arkh 2003;75:23-26.
11. Veldhuyzen Van Zanten S, Lauritsen K, Delchier JC, Labenz J, Argila CM De, Lind T, Treichel HC, Stubberod A, Cockeram A, Hasselgren G, Gothe L, Wrangstadh M, Sinclair P: One-week triple therapy with esomeprazole provides effective eradication of Helicobacter pylori in duodenal ulcer disease. Aliment Pharmacol Ther 2000;14:1605-1611.
12. Tulassay Z, Kryszewski A, Dite P, Kleczkowski D, Rudzinski J, Bartuzi Z, Hasselgren G, Larko A, Wrangstadh M: One week of treatment with esomeprazole-based triple therapy eradicates Helicobacter pylori and heals patients with duodenal ulcer disease. Eur J Gastroenterol Hepatol 2001;13:1457-1465.
13. Zhang YT, Jiang Y, Li P: The comparison of esomeprazole- and omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori infection. Acad J Guangdong Pharmacy 2004;20:561-563.
14. Xie SB: Esomeprazole-based triple therapy for Helicobacter pylori correlated peptic ulcer for 32 cases. Clin Drug 2005;14:76.
15. Gisbert JP, Pajares JM: Systematic review and meta-analysis: is 1-week proton pump inhibitor based triple therapy sufficient to heal peptic ulcer? Aliment Pharmacol Ther 2005;21:795-804.
16. Vergara M, Vallve M, Gisbert JP, Calvet X: Meta-analysis: comparative efficacy of different proton-pump inhibitors in triple therapy for Helicobacter pylori eradication. Aliment Pharmacol Ther 2003;18:647-654.
17. Sauerland S, Seiler CM: Role of systematic reviews and meta-analysis in evidence-based medicine. World J Surg 2005;29:582-587.
18. Jadad AR, Moore A, Carrol D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ: Assessing the quality of reports of randomized clinical trials: is blinding necessary. Control Clin Trials 1996;17:1.
19. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ: Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-789.
20. Madisch A, Bayerdoerffer E, Baestlein E, Consolazio A, Pica R, Rivera M, Palladini D, Nardi F, Paoluzi P: Seven-day triple therapy with esomeprazole, levofloxacin and amoxicillin is effective in patients with metronidazole- and clarithromycin-sensitive and -resistant H. pylori strains. Gastroenterology 2003;124:772.
21. Miehlke S, Ebert S, Kirsch C, Haferland C, Buchner M, Neumeyer M, Vieth M, Stolte M, Lehn N, Bayerdorffer E: One-week triple therapy with esomeprazole, clarithromycin and metronidazole is highly effective in eradicating Helicobacter pylori in the absence of antimicrobial resistance - a prospective randomized multicenter trial. Gastroenterology 2003;124:M1493.
22. Rodriguez-Torres M, Salgado-Mercado R, Rios-Bedoya CF, Aponte-Rivera E, Marxuach-Cuetara AM, Rodriguez-Orengo JF, Fernandez-Carbia A: High eradication rates of Helicobacter pylori infection with first-and second-line combination of esomeprazole, tetracycline, and metronidazole in patients allergic to penicillin. Dig Dis Sci 2005;50:634-639.
23. Gatta L, Perna F, Figura N, Ricci C, Holton J, D'Anna L, Miglioli M, Vaira D: Antimicrobial activity of esomeprazole vs. omeprazole against Helicobacter pylori. J Antimicrob Chemother 2003;51:439-442.
24. Oderda G, Marinello D, Lerro P, Kuvidi M, de'Angelis GL, Ferzetti A, Cucchiara S, Franco MT, Romano C, Strisciuglio P, Pensabene L: Dual vs. triple therapy for childhood Helicobacter pylori gastritis: a double-blind randomized multicentre trial. Helicobacter 2004;9:293-301.
25. Gisbert JP, Dominguez-Munoz A, Dominguez-Martin A, Gisbert JL, Marcos S: Esomeprazole-based therapy in Helicobacter pylori eradication: any effect by increasing the dose of esomeprazole or prolonging the treatment? Am J Gastroenterol 2005;100:1935-1940.
26. 2-receptor antagonist- and proton-pump inhibitor-based triple regimens for the eradication of Helicobacter pylori in Chinese patients with gastritis or peptic ulcer. J Int Med Res 2003;31:469-474.
27. 2-receptor antagonists - their efficacy with antibiotics in Helicobacter pylori eradication. Aliment Pharmacol Ther 2003;18:757-766.
28. Higgins JP, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-analyses. BMJ 2003;327:557-560.